Skip to content


Featured article: Antidepressants in bipolar depression: An enduring controversy

"The proper place and the optimal use of antidepressants in treating bipolar depression continues to be an area of great interest and greater controversy with passionate opinions more common than good studies. Even the handful of meta-analyses in the area disagree with each other. 

Until we have a larger data base, the question of antidepressants for bipolar depression will continue to generate more heat than light to the detriment of patients and clinicians alike."

In this review, Michael Gitlin examines the ongoing disagreements on the subject of using antidepressants for bipolar disorder, as the first in our series on Controversies in Bipolar Disorders.


  1. Content type: Letter to the Editor


    Authors: Manuel E Fuentes Salgado, Bruce Sutor, Robert C Albright and Mark A Frye

Most accessed articles RSS

View all articles

Abstracting and Indexing

The International Journal of Bipolar Disorders is indexed by PubMed Central and Web of Science. All articles will be indexed in both services shortly after publication. Submit your article now!

Thematic Series: Controversies in Bipolar Disorders

New Content ItemWhile pharmacotherapy and other biological treatment options form the foundation for successful treatment of bipolar disorder for more than seven decades, several therapeutic interventions are still controversial and sometimes its applications may differ across continents, countries or clinical settings quite significantly. This collection of articles aims to present four areas of controversy and uncertainty in bipolar disorder seeking to identify reasons for some of the dilemmas and future solutions to it. Read the series here.

Aims and scope

International Journal of Bipolar Disorders is a peer-reviewed, open access online journal publishing contributions from the broad range of clinical, psychological and biological research in bipolar disorders. It collaborates with the International Group for the study of Lithium Treated Patients (IGSLi) and the Deutsche Gesellschaft für Bipolare Störungen (DGBS), and serves as the official journal of these organisations. International Journal of Bipolar Disorders invites clinicians and researchers from around the globe to submit original research articles, short research communications, reviews, guidelines, case reports, study protocols and letters to the editor that help to enhance understanding of bipolar disorders. The journal makes all articles freely available to researchers worldwide, ensuring maximum dissemination of content. Content is published online continuously to provide timely communication to the community and keep publication times to a minimum.

Society affiliation

International Journal of Bipolar Disorders is affiliated with IGSLI (International Group for The Study of Lithium Treated Patients)


Annual Journal Metrics

  • Speed
    45 days to first decision for reviewed manuscripts only
    44 days to first decision for all manuscripts
    80 days from submission to acceptance
    52 days from acceptance to publication

    185 Altmetric Mentions